Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

gment, and $13

million in the milling products segment. Impairment and

restructuring pretax charges in the year ended December 31, 2007

consisted of $30 million in the agribusiness segment, $35 million

in the edible oil products segment and $13 million in the milling

products segment. The impairment and restructuring charges for

the quarter and year ended December 31, 2007 were recorded in

cost of goods sold, other than $11 million of the edible oil

products segment total, which was recorded in selling general and

administrative expenses. Impairment and restructuring charges in

the year ended December 31, 2006 consisted of $20 million in the

agribusiness segment and $2 million in the edible oil products

segment, which were recorded in cost of goods sold, and $2

million in the fertilizer segment, which was recorded in selling

general and administrative expenses.

Note 3: Value-added-tax provision of $50 million in the quarter and year

ended December 31, 2007 in the fertilizer segment resulted from a

recent change in tax laws in several Brazilian states that will

take effect in 2008, which will make the recoverability of these

taxes uncertain.

Note 4: Total segment operating profit is the consolidated segment

operating profit of all of Bunge's operating segments. Total

segment operating profit is a non-GAAP measure and is not

intended to replace income from operations before income tax, the

most directly comparable GAAP measure. The information required

by Regulation G under the Securities Exchange Act of 1934,

including the reconciliation to income from operations before

income tax
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email: